Study the genetics behind common skin moles
Part of Cancer clinical trials.
This study looks at why some people develop melanocytic nevi (common skin moles) by examining genetic factors. It may help researchers understand the causes of moles and could guide future skin health research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have melanocytic nevi (common moles on the skin)
- You do not have a bleeding disorder
- You are not taking blood thinners (anticoagulation medicine)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin spots that might be unusual moles or early melanoma using a special microscope that sees deep into the skin. It aims to match these microscope images with genetic information to better understand these spots.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study looks at people and families with a high risk of melanoma, especially if it runs in the family or is linked to certain genetic conditions. The goal is to better understand what causes melanoma and how to detect it earlier.
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
This study looks at how certain birthmarks (nevi) change over time and might turn into melanoma. By studying tissue samples, researchers hope to better understand this process.
This study looks for genetic and environmental causes of melanoma in people up to age 30. It may help researchers understand why some young people get this type of skin cancer.
Hear when a new Melanocytic Nevi trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.